The positive safety profile to date, the evidence supporting engraftment of the cells post-implantation, and the improvements we are seeing in upper extremity motor function highlight the promising findings coming from this Phase 1 / 2a clinical trial, which will guide us as we work to design future studies.
Based on conversation with physician experts, SunTrust said it believes LJPC - 501 hits on multiple characteristics of a successful drug, including effectiveness at improving MAP, a good
safety profile, easily titratable and
positive mortality benefit as supported by a statistically significant reduction in CV SOFA score.
PROFILE * Results oriented
safety professional with over 25 years of experience in Health, Safety and Environmental (HSE) management within the renewable energy, electric power generation, petrochemical, oil and gas, construction and off shore industries * Experience in creating positive safety cultures and reducing accidents through proven safety processes and ACHIEV
safety professional with over 25 years of experience in Health,
Safety and Environmental (HSE) management within the renewable energy, electric power generation, petrochemical, oil and gas, construction and off shore industries * Experience in creating positive safety cultures and reducing accidents through proven safety processes and ACHIEV
Safety and Environmental (HSE) management within the renewable energy, electric power generation, petrochemical, oil and gas, construction and off shore industries * Experience in creating
positive safety cultures and reducing accidents through proven safety processes and ACHIEV
safety cultures and reducing accidents through proven
safety processes and ACHIEV
safety processes and ACHIEVEMENTS